V69F (p.Val69Phe) variant of CTLA4 (Cytotoxic T-lymphocyte protein 4)

V69F (p.Val69Phe) in CTLA4 (Cytotoxic T-lymphocyte protein 4) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.29 / 1. The record also includes population frequency data and structural context.

V69F (p.Val69Phe) variant details